MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0006691
Curewin Pharmaceuticals Private Limited - healthcare in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.88 Cr
▲ 36% YoY
Net profit · FY 2024
₹2.56 Lakh
Net margin 0.9%
EBITDA · FY 2024
₹14.06 Lakh
EBITDA margin 4.9%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹1 Cr
Satisfied ₹1.29 Cr
Company age
36 yrs
Est. 1990
Directors on board
3
As per MCA filings
About Curewin Pharmaceuticals Private Limited
Data last updated:
Curewin Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 09 October 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1990PTC006038. Its GSTIN is 23AABCC1614L1Z2 (Madhya Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Virendra Tare and Sindhu Tare.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15 Industrial Area Rao, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.88 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹2.56 Lakh (net margin 0.9%) and EBITDA of ₹14.06 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 436% over three years and 12% over five years.
The company is associated with 1 brand: Curewin Pharma. As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹1.29 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 3 cases are pending.
Curewin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0006691). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curewinpharma.com.
Company details
CIN U24232MP1990PTC006038
Registration Number 006038
Incorporation Date 09 October 1990
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0006691
Recognitions & Rankings of Curewin Pharmaceuticals
Contact details
Curewin Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its website is curewinpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address15 Industrial Area Rao, Indore, Madhya Pradesh, India – 452001
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Curewin Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Curewin Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Curewin Pharmaceuticals operates one associated brand: Curewin Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Ayurvedic pharmaceutical products for health and personal care in India. | curewinpharma.com |
Business activity
The main business activity of Curewin Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Curewin Pharmaceuticals Private Limited, buy the company report.
Financials of Curewin Pharmaceuticals Private Limited
FY 2025 filings availableCurewin Pharmaceuticals Private Limited reported revenue of ₹2.88 Cr (up 36% YoY) for FY 2024.
Revenue · FY 2024
₹2.88 Cr ▲ 36%
Net profit · FY 2024
₹2.56 Lakh margin 0.9%
EBITDA · FY 2024
₹14.06 Lakh margin 4.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 436%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 386%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 36% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curewin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Curewin Pharmaceuticals Private Limited
Curewin Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Virendra Tare | Director | 06 May 2016 | 10 Years 5 Months | Current |
| Sindhu Tare | Director | 01 Apr 2005 | 21 Years 6 Months | Current |
| Rajendra Tare | Director | 21 Apr 2008 | 18 Years 6 Months | Current |
Auditor
Curewin Pharmaceuticals Private Limited is audited by SUNIL CHANDRA GOYAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL CHANDRA GOYAL & CO. | FY 2023 | 002658C |
Shareholding
The shareholding of Curewin Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Curewin Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
₹1.29 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Oct 2011 | 10312645 | Hdfc Bank Limited | ₹1 Cr | Open | |
| 09 Mar 2021 | 100444760 | Hdfc Bank Limited | ₹10 Lakh | Satisfied | |
| 19 Nov 2009 | 10193517 | State Bank of Indore | ₹3.5 Lakh | Satisfied | |
| 06 Oct 2005 | 90210100 | State Bank of India | ₹1 Cr | Satisfied | |
| 04 Jul 2005 | 90206393 | Hdfc Bank Ltd | ₹1.5 Lakh | Satisfied |
To see the full charge records of Curewin Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Curewin Pharmaceuticals Private Limited has 7 court cases on record: 2 filed by Curewin Pharmaceuticals, 5 filed against it. 3 cases are pending and 4 are disposed.
Total cases
7
Filed by the company
2
Filed against the company
5
Pending
3
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 3 |
| Supreme Court | 3 | 3 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (COMMS) | Filed against the company by Curewin- Hylico Pharma Private Limited Through Director Uttar Kumar Rao | Pending |
| District court, Indore, Madhya Pradesh | Court case (COMMS) | Filed by the company against Curewin-Hylico Pharma Pvt.Ltd. and 1 other | Pending |
| Supreme Court | Interim or miscellaneous application | Filed against the company by Curewin Hylico Pharma Pvt. Ltd. | Disposed |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by Curewin Hylico Pharma Pvt. Ltd. | Disposed |
| High Court, TELANGANA | Court case (COMCA) | Filed against the company by Curewin Ilylico Pharma Private Limited | Disposed |
To see the full case history of Curewin Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Curewin Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 54 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Mantra Packaging | |||
| an individual supplier |
To see the full MSME payment records of Curewin Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Curewin Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCC1614L1Z2 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Curewin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Curewin Pharmaceuticals Private Limited has 9 board changes on record since 2005: 4 appointments and 5 cessations. The latest: Archana Tare ceased to be Director on 20 Jan 2024.
AGM
Curewin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 09 Mar 2021 via Charge ID 100444760 with Hdfc Bank Limited was fully satisfied on 24 Jul 2025.
Filing
Curewin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Archana Tare ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Lakh with Charge ID 100444760 was registered on 09 Mar 2021.
Ceased
Sanjay Vishwanath Tiwari ceased to be Additional Director.
Charges
A charge registered on 04 Jul 2005 via Charge ID 90206393 with Hdfc Bank Ltd was fully satisfied on 14 Jan 2020.
Appointed
Sanjay Vishwanath Tiwari was appointed as Director.
Charges
A charge registered on 19 Nov 2009 via Charge ID 10193517 with State Bank Of Indore was fully satisfied on 17 May 2018.
Charges
A charge registered on 06 Oct 2005 via Charge ID 90210100 with State Bank Of India was fully satisfied on 17 May 2018.
Charges
A charge registered on 18 Jul 1998 via Charge ID 90205372 with State Bak Of Indore was fully satisfied on 17 May 2018.
Charges
A charge registered on 28 Jan 1998 via Charge ID 90208139 with State Bak Of Indore was fully satisfied on 17 May 2018.
19 earlier events are in the company report.
Frequently asked questions
Curewin Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 09 October 1990 (36+ years old) and is registered under CIN U24232MP1990PTC006038.
Curewin Pharmaceuticals has 3 current directors:
- Virendra Tare - Director
- Sindhu Tare - Director
- Rajendra Tare - Director
The latest financial statements of Curewin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Curewin Pharmaceuticals is 23AABCC1614L1Z2, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Curewin Pharmaceuticals is U24232MP1990PTC006038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curewin Pharmaceuticals has 7 court cases on record: 2 filed by the company and 5 filed against it. 3 are pending. Most are in the district courts.
Curewin Pharmaceuticals was incorporated on 09 October 1990, making it 36+ years old. It is registered with the Registrar of Companies, Gwalior.
Archana Tare ceased to be Director on 20 Jan 2024. Sanjay Vishwanath Tiwari ceased to be Additional Director on 31 Dec 2020. Sanjay Vishwanath Tiwari was appointed as Director on 06 Nov 2019. Curewin Pharmaceuticals has 9 board changes on record in total.
Yes, Curewin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0006691).
Curewin Pharmaceuticals has 3 MSME Form 1 returns on record between 2019 and 2020, listing 54 overdue payments to 10 micro and small suppliers. The latest return was filed on 26 Sep 2020.
Curewin Pharmaceuticals can be reached through the website curewinpharma.com. Its registered office is in Indore, Madhya Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages